These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28458429)

  • 1. Pricing and components analysis of some key essential pediatric medicine in Odisha state.
    Samal S; Swain TR
    Indian J Pharmacol; 2017; 49(1):89-92. PubMed ID: 28458429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pricing and availability of some essential child specific medicines in Odisha.
    Swain TR; Rath B; Dehury S; Tarai A; Das P; Samal R; Samal S; Nayak H
    Indian J Pharmacol; 2015; 47(5):496-501. PubMed ID: 26600637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prices & availability of common medicines at six sites in India using a standard methodology.
    Kotwani A; Ewen M; Dey D; Iyer S; Lakshmi PK; Patel A; Raman K; Singhal GL; Thawani V; Tripathi S; Laing R
    Indian J Med Res; 2007 May; 125(5):645-54. PubMed ID: 17642500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
    Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
    PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.
    Cameron A; Ewen M; Ross-Degnan D; Ball D; Laing R
    Lancet; 2009 Jan; 373(9659):240-9. PubMed ID: 19042012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon.
    Abdel Rida N; Mohamed Ibrahim MI; Babar ZUD
    BMC Health Serv Res; 2019 Dec; 19(1):973. PubMed ID: 31852546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China.
    Sun X; Wei J; Yao Y; Chen Q; You D; Xu X; Dai J; Yao Y; Sheng J; Li X
    BMJ Open; 2018 Oct; 8(10):e023646. PubMed ID: 30341137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prices people pay for medicines in Zimbabwe.
    Gavaza P; Simoyi T; Makunike B; Maponga CC
    Cent Afr J Med; 2009; 55(1-4):14-9. PubMed ID: 21977842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Availability, affordability and costs of pediatric medicines in Mongolia.
    Dorj G; Sunderland B; Sanjjav T; Dorj G; Gendenragchaa B
    BMC Pediatr; 2018 May; 18(1):149. PubMed ID: 29720129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Price, availability and affordability of medicines.
    Mhlanga BS; Suleman F
    Afr J Prim Health Care Fam Med; 2014 Jun; 6(1):E1-6. PubMed ID: 26245401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
    Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
    Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Availability and affordability of antimalarial and antibiotic medicines in Malawi.
    Khuluza F; Heide L
    PLoS One; 2017; 12(4):e0175399. PubMed ID: 28419126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.
    Babar ZU; Ibrahim MI; Singh H; Bukahri NI; Creese A
    PLoS Med; 2007 Mar; 4(3):e82. PubMed ID: 17388660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability, prices and affordability of essential medicines in Zhejiang Province, China.
    Dong Z; Tao Q; Yan B; Sun G
    PLoS One; 2020; 15(11):e0241761. PubMed ID: 33232336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy.
    Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S
    Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the Brazilian pharmaceutical policy ensuring population access to essential medicines?
    Bertoldi AD; Helfer AP; Camargo AL; Tavares NU; Kanavos P
    Global Health; 2012 Mar; 8():6. PubMed ID: 22436555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China.
    Yang H; Dib HH; Zhu M; Qi G; Zhang X
    Health Policy Plan; 2010 May; 25(3):219-29. PubMed ID: 19955093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Availability of generic drugs in the public sector and prices in the private sector in different regions of Brazil].
    Miranda ES; Pinto Cdu B; dos Reis AL; Emmerick IC; Campos MR; Luiza VL; Osorio-de-Castro CG
    Cad Saude Publica; 2009 Oct; 25(10):2147-58. PubMed ID: 19851615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prices, availability and affordability of medicines in Rwanda.
    Bizimana T; Kayumba PC; Heide L
    PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.